Trending - Altmetric
- Fasting-mimicking diet is safe and reshapes metabolism and antitumor immunity in cancer patientsLast mentioned on Sun Nov 28 2021
- Tumor genomic profiling guides metastatic gastric cancer patients to targeted treatment: The VIKTORY Umbrella TrialLast mentioned on Wed Nov 24 2021
- AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung CancerLast mentioned on Wed Nov 24 2021
- Implementing a functional precision medicine tumor board for acute myeloid leukemiaLast mentioned on Fri Nov 26 2021
- EP300 selectively controls the enhancer landscape of MYCN-amplified neuroblastomaLast mentioned on Sat Nov 27 2021
- Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare CancersLast mentioned on Thu Nov 25 2021
- Detecting Liquid Remnants of Solid Tumors: Circulating Tumor DNA Minimal Residual DiseaseLast mentioned on Sun Nov 28 2021
- Repurposing vandetanib plus everolimus for the treatment of ACVR1-mutant diffuse intrinsic pontine gliomaLast mentioned on Thu Nov 18 2021
- DIPG harbour alterations targetable by MEK inhibitors, with acquired resistance mechanisms overcome by combinatorial inhibitionLast mentioned on Mon Nov 15 2021
- Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?Last mentioned on Sun Nov 14 2021
- Prolonged SARS-CoV-2 infection in patients with lymphoid malignanciesLast mentioned on Sat Nov 27 2021
- Redox Regulation in Cancer Cells during MetastasisLast mentioned on Thu Nov 25 2021
- Fundamental Mechanisms of Immune Checkpoint Blockade TherapyLast mentioned on Thu Nov 18 2021
- Single-cell atlas of lineage states, tumor microenvironment and subtype-specific expression programs in gastric cancerLast mentioned on Mon Nov 15 2021
- PTP1B is an intracellular checkpoint that limits T cell and CAR T cell anti-tumor immunityLast mentioned on Sun Nov 28 2021
- Selective Requirement of MYB for Oncogenic Hyperactivation of a Translocated Enhancer in LeukemiaLast mentioned on Sat Nov 27 2021
- An in vivo CRISPR screening platform for prioritizing therapeutic targets in AMLLast mentioned on Wed Nov 10 2021
- Paradigms on Immunotherapy Combinations with ChemotherapyLast mentioned on Thu Nov 04 2021
- Highly Focused Radiation May Curb OligoprogressionLast mentioned on Fri Nov 19 2021
- Endogenous Retroelements and the Viral Mimicry Response in Cancer Therapy and Cellular HomeostasisLast mentioned on Wed Nov 17 2021
Pages